(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 98.0%, 25g

2-HYDROXY-5-PHENYLPENTANOIC ACID, 95.0%, 250mg

2,2-Dimethylmorpholine hydrochloride, 95.0%, 1g

tert-Butyl 2-iodoacetate, 95.0%, 5g

2-Amino-2-oxoacetic acid, 95.0%, 25g

(1R-trans)-Methyl 3-hydroxycyclohexanecarboxylate, 98%, 100mg

2-[4-(1-Methyl-1-phenylethyl)phenoxy]-acetohydrazide, 95.0%, 5g

(3,4-Dichloro-phenyl)-piperidin-4-yl-amine, 98%, 1g

Guardcolumnas HPLC (analíticas) NUCLEODUR® C18 Gravedad 5 µm, 4 x 5 mm, 3 Pieza(s)

1,4-Dibromo-2-chloro-3-fluorobenzene, 97.0%, 1g

2-Fluoro-4-(trifluoromethoxy)benzyl bromide, 5g

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside>92.0%(HPLC)5g

4-ethoxy-3-{1-methyl-7-oxo-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-5-yl}benzene-1-sulfonyl chloride, 97%, 10g